Flmodafinil: 50MG 60 Capsules GMP Research Product
Flmodafinil, also identified as CRL-40,940, is a fluorinated structural analog of modafinil supplied as a premium GMP capsule-format research product. Each capsule contains 50MG Flmodafinil, with 60 capsules per bottle, providing 3,000MG total Flmodafinil content.
Flmodafinil is intended for controlled laboratory investigations involving modafinil-analog chemistry, fluorinated benzhydryl sulfinyl compounds, CNS-associated compound research, metabolic transformation, sulfoxide and sulfone characterization, analytical identification, elimination-profile research, and LC-MS method development.
Disguised Alpha Flmodafinil is supplied for researchers who require clear 50MG strength labeling, total-content transparency, GMP manufacturing standards, clean capsule presentation, product documentation, internal QA review, and direct in-house fulfillment.
Product Details
Compound: Flmodafinil
Research Identifier: CRL-40,940
Other Names: Bisfluoromodafinil / Lauflumide
Strength: 50MG per capsule
Capsule Count: 60 capsules
Total Content: 3,000MG Flmodafinil per bottle
Format: Capsule-format research product
Manufacturing Standard: GMP
Research Category: Modafinil analog / fluorinated sulfinyl compound / analytical research
Research Focus: Modafinil-analog chemistry, fluorinated benzhydryl sulfinyl compounds, CNS-associated compound research, metabolic transformation, sulfoxide and sulfone characterization, elimination-profile studies, analytical identification, and LC-MS method development.
Fluorinated Modafinil-Analog Research
50MG Capsules / 3,000MG Total Content
Flmodafinil provides a clearly labeled capsule-format research material for controlled studies involving fluorinated modafinil analogs, sulfinyl compound behavior, metabolic conversion, analytical differentiation, biological specimen detection, and compound-elimination research.
Modafinil-Analog Research
Studied as a fluorinated structural analog of modafinil in compound-comparison, analog-identification, molecular-characterization, and CNS-associated research models.
Metabolism & Elimination Models
Relevant to controlled investigations involving parent-compound detection, flmodafinil-acid and flmodafinil-sulfone metabolites, blood and urine analysis, and elimination-window research.
GMP Capsule Format
Supplied as a GMP 60-capsule research product with clear 50MG strength labeling and 3,000MG total bottle content.
Why Flmodafinil Matters in Research
Flmodafinil is chemically identified as 2-[bis(4-fluorophenyl)methylsulfinyl]acetamide. Its two fluorinated phenyl groups distinguish it structurally from modafinil and make it relevant to comparative research involving fluorinated analog design, sulfinyl-compound chemistry, molecular identification, and analytical differentiation.
Published analytical research has examined Flmodafinil alongside Modafinil, Adrafinil, and Fladrafinil. These investigations have focused on compound identification, chromatographic behavior, thermal degradation, exact-mass analysis, nuclear magnetic resonance characterization, and challenges that may arise during routine forensic or laboratory testing.
More recent research has evaluated the metabolism and elimination of Flmodafinil in blood and urine. Reported metabolites include Flmodafinil acid and Flmodafinil sulfone, making the compound relevant to metabolic-transformation studies, biological specimen analysis, detection-window research, and LC-HRMS method development.
The 50MG 60-capsule format provides researchers with a clearly documented presentation for compound-comparison studies, analytical testing, metabolic research, stability investigations, and structured laboratory inventory management. Compound-specific clinical safety, efficacy, and therapeutic utility have not been established.
- 50MG Flmodafinil per capsule
- 60 capsules per bottle
- 3,000MG total Flmodafinil content
- Also identified as CRL-40,940
- Also known as Bisfluoromodafinil and Lauflumide
- Fluorinated structural analog of Modafinil
- GMP capsule-format research product
- Relevant to fluorinated sulfinyl-compound research
- Applicable to metabolism and elimination-profile studies
- Relevant to Flmodafinil-acid and Flmodafinil-sulfone metabolite research
- Suitable for LC-HRMS, NMR, chromatographic, and analytical-method studies
- Reviewed for strength clarity, capsule presentation, labeling accuracy, documentation, and fulfillment handling
Research Applications
- Modafinil-analog comparison research
- Fluorinated benzhydryl sulfinyl compound studies
- Compound identity and molecular-characterization research
- CNS-associated compound screening
- Parent-compound metabolism studies
- Flmodafinil-acid metabolite research
- Flmodafinil-sulfone metabolite research
- Blood and urine elimination-profile studies
- Biological specimen detection research
- LC-HRMS method development
- Chromatographic separation research
- NMR characterization studies
- Exact-mass and fragmentation analysis
- Thermal degradation research
- Compound stability investigations
- Capsule-format formulation studies
Flmodafinil vs. Fladrafinil
Flmodafinil and Fladrafinil are related but distinct research compounds. Flmodafinil is identified as CRL-40,940, while Fladrafinil is identified as CRL-40,941.
Fladrafinil contains an N-hydroxyacetamide group and has been described in published metabolism research as a prodrug that is converted to Flmodafinil. The compounds should therefore not be treated as interchangeable in product labeling, analytical documentation, inventory systems, or experimental design.
This product contains Flmodafinil / CRL-40,940. It does not contain Fladrafinil / CRL-40,941 unless separately stated on the product label and batch documentation.
Conservative Interpretation of Flmodafinil Research
Flmodafinil is structurally related to Modafinil, but structural similarity does not establish identical receptor activity, potency, duration, safety, therapeutic effect, or clinical utility. Compound-specific pharmacology should be established through direct experimental evidence rather than inferred solely from its relationship to Modafinil.
Disguised Alpha therefore describes Flmodafinil as a fluorinated Modafinil analog and analytical research compound rather than presenting wakefulness, cognition, focus, productivity, or neurological effects as established product outcomes.
Why Our Quality Process Is Different
Capsule-format research products require more than a compound name and strength. Identity clarity, correct CRL-number designation, capsule consistency, total-content transparency, analytical documentation, label review, storage expectations, packaging quality, and fulfillment handling all matter.
Disguised Alpha reviews Flmodafinil as a complete GMP research product with attention to 50MG strength presentation, CRL-40,940 identity, 60-capsule bottle format, 3,000MG total-content clarity, finished capsule appearance, product documentation, internal QA, labeling accuracy, and direct fulfillment accountability.
- GMP manufacturing standard
- 50MG strength-labeling clarity
- CRL-40,940 identity transparency
- 3,000MG total-content disclosure
- Compound identity documentation review
- Finished capsule presentation checks
- Product documentation and label review
- Storage expectation review
- Internal QA before product release
- Direct in-house fulfillment with no anonymous 3PL handling
Verify Our Claims
Researchers should verify compound identity, strength, capsule count, total content, and batch documentation before beginning any study. Learn more about the independent laboratories we work with below.
The Disguised Alpha Standard
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over product presentation, fulfillment accuracy, packaging standards, storage conditions, documentation handling, and customer experience. Our goal is not to be the cheapest research supplier. It is to provide professionally handled research materials with real quality oversight behind them.
Research Use Disclaimer:
This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, animal use, medical use, diagnostic use, therapeutic use, wakefulness use, stimulant use, cognitive-enhancement use, memory-enhancement use, focus-enhancement use, productivity use, narcolepsy treatment, sleep-disorder treatment, fatigue treatment, mood-support use, athletic-performance use, doping use, capsule consumption, oral use, self-administration use, supplement use, or the treatment, prevention, or diagnosis of any disease. Compound-specific human safety, efficacy, dosing, pharmacokinetics, and clinical utility have not been established. Researchers are responsible for confirming product identity, analytical specifications, proper handling, storage, compatibility, experimental suitability, and compliance with all applicable regulations.
